drugset / Trial / NCT01460069
The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to investigate the effect of the GLP-1 analogue Victoza® on psoriasis in a double-blinded, randomized placebo-controlled clinical trial.
Timeline
- Start
- 2011-10
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Liraglutide | Peptide | 1.8 mg | Subcutaneous |